DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $795,000 | +25.0% | 9,296 | +13.8% | 0.05% | +71.4% |
Q4 2016 | $636,000 | -0.6% | 8,166 | 0.0% | 0.03% | -3.4% |
Q3 2016 | $640,000 | -22.4% | 8,166 | 0.0% | 0.03% | -19.4% |
Q2 2016 | $825,000 | +8.7% | 8,166 | +2.1% | 0.04% | +16.1% |
Q1 2016 | $759,000 | -53.6% | 7,996 | -54.6% | 0.03% | -52.3% |
Q4 2015 | $1,637,000 | +9.0% | 17,624 | 0.0% | 0.06% | +10.2% |
Q3 2015 | $1,502,000 | -0.4% | 17,624 | 0.0% | 0.06% | +31.1% |
Q2 2015 | $1,508,000 | +0.8% | 17,624 | 0.0% | 0.04% | +4.7% |
Q1 2015 | $1,496,000 | +5.4% | 17,624 | +6.4% | 0.04% | +7.5% |
Q4 2014 | $1,420,000 | +12.8% | 16,564 | 0.0% | 0.04% | +21.2% |
Q3 2014 | $1,259,000 | -3.5% | 16,564 | 0.0% | 0.03% | +3.1% |
Q2 2014 | $1,304,000 | +5.0% | 16,564 | 0.0% | 0.03% | +18.5% |
Q1 2014 | $1,242,000 | -2.9% | 16,564 | 0.0% | 0.03% | 0.0% |
Q4 2013 | $1,279,000 | +10.6% | 16,564 | -0.7% | 0.03% | +12.5% |
Q3 2013 | $1,156,000 | +9.5% | 16,677 | 0.0% | 0.02% | +14.3% |
Q2 2013 | $1,056,000 | – | 16,677 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |